| Website | deerfieldcapital.com |
| Phone | 773-380-1600 |
| Employees |
Deerfield Capital Management (“DCM”) is a global fixed-income investment adviser that has managed institutional, alternative accounts since 1993.
| Company | Date | Round | Size | Participants |
| Raptor Pharmaceuticals | 8/10 | Venture Round | $15M | 5 |
| Pacific Biosciences | 7/10 | Series F | $109M | 11 |
| N30 Pharmaceuticals | 7/10 | Series B | $10M | 3 |
| Hana Biosciences | 6/10 | Venture Round | $100M | 2 |
| CardioMEMS | 10/09 | Series F | $22.1M | 10 |
| Pacific Biosciences | 10/09 | Series E | $68M | 14 |
| Arena Pharmaceuticals | 6/09 | Series A | $100M | 1 |
| Third Wave Technologies | 12/07 | Venture Round | $25M | 1 |
| Tengion | 10/07 | Series C | $33M | 9 |
| Metabolex | 4/07 | Series D | $32M | 16 |
| Novare Surgical | 10/06 | Series D | $16M | 6 |